Notes in Oral Cavity

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	H&N \| Oral cavity \| 3.4 \| PORT \| Postoperative chemoradiotherapy
Published	02/18/2024	H&N \| Oral cavity \| 3.3 \| PORT \| Postoperative radiotherapy alone
Published	02/18/2024	H&N \| Oral cavity \| 1.1 \| Anatomy
Published	02/18/2024	H&N \| Oral cavity \| 1.2 \| Epidemiology
Published	02/18/2024	H&N \| Oral cavity \| 1.3 \| Risk factors
Published	02/18/2024	H&N \| Oral cavity \| 1.4 \| Pathologic classification
Published	02/18/2024	H&N \| Oral cavity \| 1.7 \| Staging
Published	02/18/2024	H&N \| Oral cavity \| 1.5 \| SCC \| Macroscopic and microscopic appearance
Published	02/18/2024	H&N \| Oral cavity \| 1.6.1 \| Differential diagnosis \| Overview
Published	02/18/2024	H&N \| Oral cavity \| 1.6.2 \| Differential diagnosis \| Normal variants of oral mucosa: Leukoedema, fordyce granules, physiologic pigmentation
Published	02/18/2024	H&N \| Oral cavity \| 1.6.2 \| Differential diagnosis \| White and red lesions
Published	02/18/2024	H&N \| Oral cavity \| 1.6.3 \| Differential diagnosis \| Miscellaneous \| Mucocele, Torus
Published	02/18/2024	H&N \| Oral cavity \| 1.8 \| Biologic behaviour
Published	02/18/2024	H&N \| Oral cavity \| 2.1 \| Workup
Published	02/18/2024	H&N \| Oral cavity \| 1.9.1 \| Prognosis
Published	02/18/2024	H&N \| Oral cavity \| 1.9.2 \| Prognostic factors
Published	02/18/2024	H&N \| Oral cavity \| 3.1 \| Management \| Overview
Published	02/18/2024	H&N \| Oral cavity \| 3.2 \| RT doses
Published	02/18/2024	H&N \| Oral cavity \| 3.5 \| Inoperable \| Definitive chemoradiotherapy
Published	02/18/2024	H&N \| Oral cavity \| 5 \| Treatment technique \| Adjuvant RT
Published	02/18/2024	H&N \| Oral cavity \| 3.6 \| Ongoing trials
Published	02/18/2024	H&N \| Oral cavity \| 4.1.1 \| Subsites \| Lip \| Epidemiology, RFs, Pathology, Biologic behaviour
Published	02/18/2024	H&N \| Oral cavity \| 4.1.2 \| Subsites \| Lip \| Management
Published	02/18/2024	H&N \| Oral cavity \| 4.1.2.2 \| Subsites \| Lip \| RT technique
Published	02/18/2024	H&N \| Oral cavity \| 4.4 \| Subsites \| Upper alveolus / hard palate
Published	02/18/2024	H&N \| Oral cavity \| 4.5 \| Subsites \| Lower alveolus / retromolar trigone
Published	02/18/2024	H&N \| Oral cavity \| 4.6 \| Subsites \| Buccal mucosa
Published	02/18/2024	H&N \| Oral cavity \| 5.1 \| Benefits of IMRT
Published	02/18/2024	H&N \| Oral cavity \| 5.2 \| CTV by subsite
Published	02/18/2024	H&N \| Oral cavity \| 5.3 \| Determinants of functional outcome
Published	02/18/2024	H&N \| Oral cavity \| 5.4 \| Speech and swallow rehab
Published	02/18/2024	H&N \| Oral cavity \| 5.5 \| Notes on dysphagia
Published	02/18/2024	H&N \| Oral cavity \| 3.0 \| Management overview
Published	02/18/2024	H&N \| Oral cavity \| 4.2 \| Subsites \| Oral tongue
Published	02/18/2024	H&N \| Oral cavity \| 4.3 \| Subsites \| Floor of mouth
Published	02/18/2024	H&N \| Oral cavity \| 3.1.2 \| Surgical principles - mandibulectomy, reconstruction
Published	02/18/2024	H&N \| Oral cavity \| 3.1.3 \| cN0 neck management
Published	02/18/2024	H&N \| H&NSCC General \| 2.8.4 \| Definitive RT \| Gastrostomy tubes
Status	Last Update	Fields